Búsqueda | Portal de Búsqueda de la BVS España

1.

Phase 2 study of epigenetic priming with decitabine followed by cytarabine for acute myeloid leukemia in older patients.

Im, Annie; Quann, Kevin; Agha, Mounzer; Raptis, Anastasios; Redner, Robert L; Hou, Jing-Zhou; Farah, Rafic; Dorritie, Kathleen A; Sehgal, Alison R; Normolle, Daniel; Bovbjerg, Dana H; Aggarwal, Nidhi; Herman, James; Lontos, Konstantinos; Boyiadzis, Michael.

Am J Hematol; 99(3): 380-386, 2024 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-38258329

2.

Entospletinib with decitabine in acute myeloid leukemia with mutant TP53 or complex karyotype: A phase 2 substudy of the Beat AML Master Trial.

Duong, Vu H; Ruppert, Amy S; Mims, Alice S; Borate, Uma; Stein, Eytan M; Baer, Maria R; Stock, Wendy; Kovacsovics, Tibor; Blum, William; Arellano, Martha L; Schiller, Gary J; Olin, Rebecca L; Foran, James M; Litzow, Mark R; Lin, Tara L; Patel, Prapti A; Foster, Matthew C; Redner, Robert L; Al-Mansour, Zeina; Cogle, Christopher R; Swords, Ronan T; Collins, Robert H; Vergilio, Jo-Anne; Heerema, Nyla A; Rosenberg, Leonard; Yocum, Ashley O; Marcus, Sonja; Chen, Timothy; Druggan, Franchesca; Stefanos, Mona; Gana, Theophilus J; Shoben, Abigail B; Druker, Brian J; Burd, Amy; Byrd, John C; Levine, Ross L; Boyiadzis, Michael M.

Cancer; 129(15): 2308-2320, 2023 08 01.

Artículo en Inglés | MEDLINE | ID: mdl-37078412

3.

A prospective study of the use of central venous catheters in patients newly diagnosed with acute myeloid leukemia treated with induction chemotherapy.

McKeown, Christi; Ricciuti, Asha; Agha, Mounzer; Raptis, Anastasios; Hou, Jing-Zhou; Farah, Rafic; Redner, Robert L; Im, Annie; Dorritie, Kathleen A; Sehgal, Alison; Rossetti, James; Lontos, Konstantinos; Bovbjerg, Dana H; Normolle, Daniel; Boyiadzis, Michael.

Support Care Cancer; 30(2): 1673-1679, 2022 Feb.

Artículo en Inglés | MEDLINE | ID: mdl-34562168

4.

Phase 1 clinical trial of adoptive immunotherapy using "off-the-shelf" activated natural killer cells in patients with refractory and relapsed acute myeloid leukemia.

Boyiadzis, Michael; Agha, Mounzer; Redner, Robert L; Sehgal, Alison; Im, Annie; Hou, Jing-Zhou; Farah, Rafic; Dorritie, Kathleen A; Raptis, Anastasios; Lim, Seah H; Wang, Hong; Lapteva, Natalia; Mei, Zhuyong; Butterfield, Lisa H; Rooney, Cliona M; Whiteside, Theresa L.

Cytotherapy; 19(10): 1225-1232, 2017 10.

Artículo en Inglés | MEDLINE | ID: mdl-28864289

5.

Outcomes of patients diagnosed with acute myeloid leukemia after solid organ transplantation.

Lontos, Konstantinos; Agha, Mounzer; Raptis, Anastasios; Hou, Jing-Zhou; Farah, Rafic; Redner, Robert L; Im, Annie; Dorritie, Kathleen A; Sehgal, Alison; Rossetti, James; Saul, Melissa; Gooding, William E; Humar, Abhinav; Boyiadzis, Michael.

Clin Transplant; 31(9)2017 Sep.

Artículo en Inglés | MEDLINE | ID: mdl-28710776

6.

Leukapheresis in patients newly diagnosed with acute myeloid leukemia.

Villgran, Vipin; Agha, Mounzer; Raptis, Anastasios; Hou, Jing-Zhou; Farah, Rafic; Lim, Seah H; Redner, Robert L; Im, Annie; Sehgal, Alison; Dorritie, Kathleen A; Kiss, Joseph E; Normolle, Daniel; Boyiadzis, Michael.

Transfus Apher Sci; 55(2): 216-220, 2016 Oct.

Artículo en Inglés | MEDLINE | ID: mdl-27470709

7.

Intensive induction chemotherapy vs hypomethylating agent-based regimen in patients aged ≥70 years with newly diagnosed acute myeloid leukemia.

Lim, Matthew J; Agha, Aya; Im, Annie; Raptis, Anastasios; Hou, Jing Z; Boyiadzis, Michael; Sehgal, Alison R; Redner, Robert L; Dorritie, Kathleen; Marks, Stanley S; Agha, Mounzer E; Lim, Seah H.

Hematol Oncol; 36(2): 495-497, 2018 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-28664979

8.

Plateletpheresis for postsplenectomy rebound thrombocytosis in a patient with chronic immune thrombocytopenic purpura on romiplostim.

Raval, Jay S; Redner, Robert L; Kiss, Joseph E.

J Clin Apher; 28(4): 321-4, 2013 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-23450778

9.

Outcomes of Patients With Acute Myeloid Leukemia Who Relapse After 5 Years of Complete Remission.

Patel, Arisha; Agha, Mounzer; Raptis, Anastasios; Hou, Jing-Zhou; Farah, Rafic; Redner, Robert L; Im, Annie; Dorritie, Kathleen A; Sehgal, Alison; Rossetti, James; Saul, Melissa; Normolle, Daniel; Lontos, Konstantinos; Boyiadzis, Michael.

Oncol Res; 28(7): 811-814, 2021 Sep 07.

Artículo en Inglés | MEDLINE | ID: mdl-32753091

10.

Why doesn't imatinib cure chronic myeloid leukemia?

Redner, Robert L.

Oncologist; 15(2): 182-6, 2010.

Artículo en Inglés | MEDLINE | ID: mdl-20124443

11.

Improved quality of life for romiplostim-treated patients with chronic immune thrombocytopenic purpura: results from two randomized, placebo-controlled trials.

George, James N; Mathias, Susan D; Go, Ronald S; Guo, Matthew; Henry, David H; Lyons, Roger; Redner, Robert L; Rice, Lawrence; Schipperus, Martin R.

Br J Haematol; 144(3): 409-15, 2009 Feb.

Artículo en Inglés | MEDLINE | ID: mdl-19016720

12.

Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial.

Kuter, David J; Bussel, James B; Lyons, Roger M; Pullarkat, Vinod; Gernsheimer, Terry B; Senecal, Francis M; Aledort, Louis M; George, James N; Kessler, Craig M; Sanz, Miguel A; Liebman, Howard A; Slovick, Frank T; de Wolf, J Th M; Bourgeois, Emmanuelle; Guthrie, Troy H; Newland, Adrian; Wasser, Jeffrey S; Hamburg, Solomon I; Grande, Carlos; Lefrère, François; Lichtin, Alan Eli; Tarantino, Michael D; Terebelo, Howard R; Viallard, Jean-François; Cuevas, Francis J; Go, Ronald S; Henry, David H; Redner, Robert L; Rice, Lawrence; Schipperus, Martin R; Guo, D Matthew; Nichol, Janet L.

Lancet; 371(9610): 395-403, 2008 Feb 02.

Artículo en Inglés | MEDLINE | ID: mdl-18242413

13.

Effect of a proton pump inhibitor on the pharmacokinetics of imatinib.

Egorin, Merrill J; Shah, Dhvani D; Christner, Susan M; Yerk, Mara A; Komazec, Kristin A; Appleman, Leonard R; Redner, Robert L; Miller, Brian M; Beumer, Jan H.

Br J Clin Pharmacol; 68(3): 370-4, 2009 Sep.

Artículo en Inglés | MEDLINE | ID: mdl-19740393

14.

Inhibition of Src family kinases enhances retinoic acid induced gene expression and myeloid differentiation.

Miranda, Michelle B; Redner, Robert L; Johnson, Daniel E.

Mol Cancer Ther; 6(12 Pt 1): 3081-90, 2007 Dec.

Artículo en Inglés | MEDLINE | ID: mdl-18065491

15.

Prognostic significance of blast immunophenotype on first post-induction bone marrow biopsy.

Lontos, Konstantinos; Tsagianni, Anastasia; Agha, Mounzer; Raptis, Anastasios; Hou, Jing-Zhou; Farah, Rafic; Redner, Robert L; Im, Annie; Dorritie, Kathleen A; Sehgal, Alison; Rossetti, James; Aggarwal, Nidhi; Saul, Melissa; Boyiadzis, Michael; Bailey, Nathanael G.

Leuk Lymphoma; 64(3): 750-752, 2023 03.

Artículo en Inglés | MEDLINE | ID: mdl-36722791

16.

A phase-1 study of dasatinib plus all-trans retinoic acid in acute myeloid leukemia.

Redner, Robert L; Beumer, Jan H; Kropf, Patricia; Agha, Mounzer; Boyiadzis, Michael; Dorritie, Kathleen; Farah, Rafic; Hou, Jing-Zhao; Im, Annie; Lim, Seah H; Raptis, Anastasios; Sehgal, Alison; Christner, Susan M; Normolle, Daniel; Johnson, Daniel E.

Leuk Lymphoma; 59(11): 2595-2601, 2018 11.

Artículo en Inglés | MEDLINE | ID: mdl-29616864

17.

Knee pain: ACL, MCL, or CML?

Novelli, Enrico M; Redner, Robert L.

Blood; 115(26): 5287, 2010 Jul 01.

Artículo en Inglés | MEDLINE | ID: mdl-20614568

18.

A nomogram using cytogenetics, TP53, and NPM1 mutational status can predict responses to induction chemotherapy in AML.

Lontos, Konstantinos; Tsagianni, Anastasia; Agha, Mounzer; Raptis, Anastasios; Hou, Jing-Zhou; Farah, Rafic; Redner, Robert L; Im, Annie; Dorritie, Kathleen A; Sehgal, Alison; Rossetti, James; Aggarwal, Nidhi; Saul, Melissa; Gooding, William; Boyiadzis, Michael.

Leuk Lymphoma; 63(13): 3257-3260, 2022 12.

Artículo en Inglés | MEDLINE | ID: mdl-36075047

19.

The NPM-RAR fusion protein associated with the t(5;17) variant of APL does not interact with PML.

Rush, Elizabeth A; Schlesinger, Kimberly W; Watkins, Simon C; Redner, Robert L.

Leuk Res; 30(8): 979-86, 2006 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-16504291

20.

Gemtuzumab ozogamicin, mitoxantrone, and etoposide in newly diagnosed acute myeloid leukemia patients with persistent leukemia after a course of induction therapy.

Boyiadzis, Michael; Redner, Robert L; Raptis, Anastasios; Hou, Jing-Zhou; Agha, Mounzer; Foon, Kenneth A.

Ann Hematol; 90(6): 733-5, 2011 Jun.

Artículo en Inglés | MEDLINE | ID: mdl-20857113

Portal de Búsqueda de la BVS España

Información y Conocimiento para la Salud

Configurar filtros

Su selección (0)

Formato de exportación:

Exportar: